Vertical: HealthcareBase Year: 202429 Sections
Market Size (2024)
$2.65B
Projected (2035)
$6.89B
CAGR (2019–2035)
8.2%
Key Players
12+
This report covers Tissue Adhesives Market with forecasts from 2019 to 2035. 12 key companies are profiled.
The Tissue Adhesives Market market is projected to grow at a CAGR of 8.2% from 2019 to 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe increasing surgical procedures, technological advancements in tissue adhesive products, and aging population across the globe are driving the global tissue adhesives market. However, increasing demand for environmental and biodegradable adhesives, expansion in surgical applications, and focus on patient-centric products are restraining market expansion. Despite these barriers, high cost of advanced tissue adhesives, risk of adhesive failure, and regulatory hurdles, are expected to create significant growth opportunities for the market in the future. High cost of advanced tissue adhesives
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2024
Historical Period
2019 – 2023
Forecast Period
2025 – 2035
Primary Interviews
150+
Historical data (2019–2024) and forecast period (2024–2035)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter's Five Forces model is a framework to study the global collagen and hyaluronic acid Intra-articular injections market. Strategic business managers trying to gain an edge over competing firms in the global collagen and hyaluronic acid Intra-articular Injections Market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the global collagen and hyaluronic acid Intra-articular injections market have been broken down and analyzed.
PORTER'S FIVE FORCES ANALYSIs: Global Collagen and Hyaluronic acid Intra-articular Injections Market
Threat of New Entrants
The threat of new entrants in the global collagen and hyaluronic acid intra-articular injections market is moderate to high. While the market presents lucrative opportunities due to the rising prevalence of osteoarthritis and joint disorders, significant barriers exist for new players. These include stringent regulatory requirements, high R&D costs, and the need for advanced manufacturing capabilities. Established brands with strong patents and loyal customer bases further deter new entrants. However, the growing demand for minimally invasive treatments and the emergence of biosimilars and generic products create opportunities for smaller companies to enter the market. Additionally, advancements in biotechnology and partnerships with research institutions can lower entry barriers, enabling new players to compete effectively in this dynamic and expanding market.
Bargaining Power of Suppliers
The bargaining power of suppliers in the global collagen and hyaluronic acid intra-articular injections market is moderate. Suppliers of raw materials, such as collagen and hyaluronic acid, hold some influence due to the specialized nature and high-quality standards required for these ingredients. The market relies on a limited number of suppliers, which can impact pricing and availability. However, manufacturers can mitigate this power by diversifying their supplier base, investing in in-house production, or developing synthetic or plant-based alternatives. While suppliers play a critical role in ensuring product quality, their bargaining power is balanced by the ability of manufacturers to adapt and seek alternative sourcing strategies.
Threat of Substitutes
The threat of substitutes in the global collagen and hyaluronic acid intra-articular injections market is high. Patients and healthcare providers have access to various alternatives, including oral medications (e.g., NSAIDs), corticosteroids, physical therapy, and surgical options like joint replacements. Emerging therapies, such as stem cell treatments and platelet-rich plasma (PRP) injections, also pose significant competition. The availability of less invasive, cost-effective, or non-pharmacological treatments reduces dependency on intra-articular injections, making the market highly susceptible to substitution pressures.
Bargaining Power of Buyers
The bargaining power of buyers in the global collagen and hyaluronic acid intra-articular injections market is moderate to high. Buyers, including hospitals, clinics, and patients, have significant influence due to the availability of alternative treatments and price sensitivity. Large healthcare providers and group purchasing organizations (GPOs) can negotiate lower prices, putting pressure on manufacturers. Additionally, limited reimbursement policies in some regions make cost a critical factor for patients. However, the specialized nature of these injections and their effectiveness in treating joint disorders balance buyer power, as demand remains strong among those seeking minimally invasive and effective solutions.
Intensity of Rivalry
Intensity rivalry in the global collagen and hyaluronic acid intra-articular injections market is high. The market is dominated by established players such as Bioventus, Ferring, Sanofi, Anika Therapeutics, etc., who compete on innovation, pricing, and geographic reach. The introduction of biosimilars and generic products has intensified competition, as companies strive to offer cost-effective solutions. Additionally, the growing demand for minimally invasive treatments has attracted new entrants, further increasing rivalry. Key differentiators include product efficacy, brand reputation, and strong distribution networks. Companies are also investing in R&D to develop advanced formulations and delivery systems, ensuring they remain competitive in this dynamic and rapidly evolving market.
SCOPING, METHODOLOGY AND MARKET STRUCTURE
SCOPING, METHODOLOGY AND MARKET STRUCTURE
Market estimates by geography (2035)
InsightAPAC leads with $1.74B by 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2024 | 2035 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.44M | $0.41M | $0.38M | -0.9% | 0% |
| Europe | $0.30M | $0.30M | $0.30M | -0.0% | 0% |
| Asia-Pacific | $0.18M | $0.22M | $0.25M | 2.1% | 0% |
| APAC | $351.58M | $744.53M | $1.74B | 10.5% | 79% |
| ROW | $152.95M | $253.91M | $469.20M | 7.3% | 21% |
| Middle East and Africa | $0.40M | $0.42M | $0.44M | 0.6% | 0% |
| Total | $506.45M | $1.00B | $2.21B | 8.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$6.89B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Synthetic & Semi-Synthetic Adhesives | $3.98B | 7.5% | 28% |
| Natural Adhesives | $2.92B | 9.4% | 20% |
| Cyanoacrylates | $2.17B | 8.4% | 15% |
| Fibrin | $1.70B | 10.2% | 12% |
| Polyethylene Glycol | $1.14B | 7.4% | 8% |
| General Surgery | $1.02B | 7.2% | 7% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Tissue Adhesives Market covering market dynamics, competitive landscape, and strategic outlook.
The Tissue Adhesives Market market is projected to reach $6.89B by 2035, growing at 8.2% CAGR. The Synthetic & Semi-Synthetic Adhesives segment holds the largest share.
The increasing surgical procedures, technological advancements in tissue adhesive products, and aging population across the globe are driving the global tissue adhesives market. However, increasing demand for environmental and biodegradable adhesives, expansion in surgical applications, and focus on patient-centric products are restraining market expansion. Despite these barriers, high cost of advanced tissue adhesives, risk of adhesive failure, and regulatory hurdles, are expected to create significant growth opportunities for the market in the future. High cost of advanced tissue adhesives
The increasing number of surgical procedures worldwide is significantly boosting the growth of the global tissue adhesives market. According to the United Nations, 2023, as the global population grows and ages—1 in 6 people are now aged 65 or older, a figure projected to rise to 1 in 4 by 2050 demand for both elective and emergency surgeries continue to surge. According to the Wantstats secondary analysis, over 360 million major surgical procedures were performed globally in 2023, driven by aging demographics and chronic disease prevalence. Moreover, 2024 Annals of Surgery meta-analysis highlighted that tissue adhesives are increasingly preferred by surgeons for wound closure due to their advantages over traditional sutures, including 30–50% faster application times and a 35% reduction in surgical site infections. Additionally, patients treated with tissue adhesives experience 20–25% shorter recovery periods, which is critical for improving post-operative outcomes. The global tissue adhesives market is projected to grow at a significant rate, fuelled by adoption in specialties such as dermatology, orthopedics, and cardiovascular surgery.
For instance, American Society for Dermatologic Surgery, Dermatologists who are members of the American Society for Dermatologic Surgery (ASDS carried out almost 14 million medically essential and cosmetic procedures in 2019, marking an 11% increase from 2018 and a 78% rise since 2012 with tissue adhesives preferred for minimizing scarring in cosmetic surgeries. According to the European Commission, in 2022, a total of 1.06 million transluminal coronary angioplasty procedures were performed across the 25 EU countries with available data. This represents an increase of more than 3,500 procedures compared to 2017. As per the, Journal of Minimally Invasive Surgery, 2024, with 85% of surgeries expected to adopt minimally invasive techniques by 2030, tissue adhesives are pivotal in reducing complications such as postoperative leakage by 40% and enhancing patient satisfaction. This trend underscores their essential role in advancing surgical precision, efficiency, and recovery outcomes worldwide. Technological advancements in tissue adhesive products have significantly contributed to the growth of the global tissue adhesives market. Innovations such as bio-inspired adhesives, nanotechnology, and improved polymer chemistry have led to the development of more efficient, biocompatible, and stronger adhesives.
For instance, a 2023 study in Nature Biomedical Engineering highlighted that advanced polymer-based adhesives reduce wound closure time by 25% compared to traditional methods, while nanotechnology-enhanced formulations improve tensile strength by over 30%. These advancements enable tissue adhesives to bond better with human tissue, promote faster wound healing, and reduce the risk of infection, which is critical given that surgical site infections (SSIs) affect up to 5% of postoperative patients globally reported by WHO, 2023. Moreover, the introduction of new delivery systems, such as spray and gel forms, has accelerated adoption. According to the Journal of Clinical Medicine, 2023, the growing preference for minimally invasive procedures—expected to account for 72% of all surgeries by 2025—has further boosted demand, as tissue adhesives offer a suture-free alternative that minimizes scarring and recovery time. As these technologies evolve, they promise not only enhanced patient outcomes but also increased adoption across diverse healthcare settings. This trajectory positions the global tissue adhesives market for sustained growth, aligning with broader shifts toward efficient, patient-centric care. The aging population across the globe is a key driver of the growth in the global tissue adhesive market.
As per America’s Health Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022, and this number was projected to grow nearly 22% in the US in 2040. According to the European Commission, there were 448.8 million people, and more than one fifth of them were aged 65 years and over in Europe. As per the Asia-Pacific Report on Population Ageing 2022, there were approximately 670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately 1.3 billion people by 2050 in Asia-Pacific. According to the United Nations, 2023, age-related health conditions such as chronic wounds, surgical procedures, and skin injuries are more susceptible. Moreover, the National Institute on Aging, 2023, chronic wounds alone affect 2.5% of the elderly population annually, driving demand for efficient wound management solutions like tissue adhesives. Tissue adhesives, offering a quicker, less painful, and minimally invasive alternative to traditional sutures and staples, are increasingly preferred for treating older adults. Journal of the American Geriatrics Society, 2024 studies indicate that tissue adhesives reduce procedure time by 30–50% compared to sutures, critical for elderly patients with comorbidities.
Furthermore, Wound Repair and Regeneration, 2023, reported that advanced adhesives improve healing outcomes in older adults, whose wound healing capacity is 40% slower than younger individuals, by reducing infection risks and accelerating recovery. Additionally, OECD Health Statistics, 2023, stated that the rising demand for safer, easier-to-apply treatments is evident, with 62% of surgeons in geriatric care now prioritizing adhesives for superficial wounds and post-surgical closures. This trend aligns with the broader shift toward outpatient care, where tissue adhesive use in elderly patients has surged. As the aging demographic expands, healthcare systems wor
The increasing demand for environmental and biodegradable adhesives is creating significant opportunities for the global tissue adhesives market, driven by growing concerns over sustainability and environmental impact. Consumers and healthcare providers are becoming more conscious of the ecological footprint of medical products, prompting a shift toward eco-friendly alternatives. Biodegradable tissue adhesives, made from natural polymers or bio-based materials, are gaining traction as they offer the benefit of minimizing environmental waste, especially in disposable medical products. These adhesives not only reduce the need for synthetic materials, which can be harmful to the environment, but they also degrade naturally over time, reducing long-term ecological impact. As the healthcare industry increasingly prioritizes green practices and regulatory bodies introduce stricter environmental guidelines, manufacturers are investing in the development of biodegradable adhesives that provide high performance without compromising patient safety or treatment efficacy. This shift toward sustainable products is creating new growth avenues within the tissue adhesives market, appealing to both environmentally conscious consumers and healthcare systems seeking eco-friendly solutions. The trend toward biodegradable tissue adhesives is expected to continue to expand, further enhancing the market's growth prospects while aligning with broader sustainability goals in the healthcare sector.
The expansion of surgical applications is significantly driving the growth of the tissue adhesive market by offering more efficient and effective solutions for wound closure, organ repair, and tissue bonding. Traditional methods like sutures and staples are gradually being replaced or supplemented by tissue adhesives, which provide a faster, more precise, and less invasive alternative. Surgeons now utilize these adhesives not only for external wounds but also in complex internal surgeries, such as cardiovascular, neurological, and orthopedic procedures. The ability to close incisions or wounds without the need for stitches or staples reduces the risk of infection, minimizes scarring, and speeds up the healing process, all of which contribute to enhanced patient outcomes. As medical technology continues to advance and surgical techniques become more sophisticated, the demand for versatile tissue adhesives is expanding rapidly, creating new growth opportunities for manufacturers in the market.
Moreover, the increasing preference for minimally invasive procedures and the rise in surgeries globally further fuel the adoption of tissue adhesives, positioning them as a vital component of modern surgical practice. -CE NTRIC PRODUCTS The growing focus on patient-centric products is creating significant opportunities for the global tissue adhesives market by prioritizing ease of use, improved safety, and better overall patient experiences. As healthcare providers shift toward solutions that minimize discomfort and enhance recovery, tissue adhesives are becoming a preferred option for wound closure and healing. These adhesives are designed to be less invasive than traditional sutures, reducing patient anxiety and the potential for complications such as infection or scarring. The convenience of tissue adhesives, which allow for quicker application and potentially fewer follow- up visits, aligns with the rising demand for products that streamline patient care and improve outcomes. Additionally, patient-centric innovations such as bio-absorbable adhesives that eliminate the need for removal and adhesives with antimicrobial properties further elevate the market potential. As more healthcare systems emphasize patient satisfaction and the efficiency of care, the tissue adhesives market is poised for continued growth, driven by advancements that cater directly to patient needs and expectations.
The high cost of advanced tissue adhesives presents a significant challenge to the global tissue adhesive market, as it may limit accessibility, particularly in developing regions where over 40% of healthcare systems operate on constrained budgets, according to the OECD, 2023. JAMA Surgery (2024) and the World Health Organization (WHO, 2023) reported that advanced tissue adhesives, which offer superior performance such as 25% faster healing and a 40% reduction in infection rates compared to traditional methods, often cost 3–5 times more. This premium pricing is attributed to the use of complex materials, such as biocompatible polymers and nanotechnology-driven formulations. While this cost barrier can hinder widespread adoption, the market is poised for gradual price stabilization as production scales, technological advancements continue, and competition in the sector intensifies. As more evidence emerges regarding the long-term cost savings associated with faster recovery times and reduced post-surgical complications, the growing demand for these advanced adhesives is expected to drive market expansion and improve their accessibility in both developed and developing regions.
The risk of adhesive failure is a significant restraint in the growth of the global tissue adhesives market, as it raises concerns about the reliability and safety of these products, particularly in critical surgical applications. While tissue adhesives offer several advantages, such as faster application and less patient discomfort compared to traditional sutures, the potential for adhesive failure remains a key challenge. Factors such as improper application, patient-specific reactions, and the quality of the adhesive material can contribute to bond failure, leading to wound dehiscence, delayed healing, or infection. According to JAMA Surgery (2024), adhesive failure can occur in approximately 3-5% of cases, depending on the product and its use. This risk of failure is particularly concerning in complex surgeries or when applied to areas with high tension, where the adhesive may not provide adequate support. Additionally, the long-term durability of tissue adhesives under various environmental conditions, such as moisture or movement, is still a topic of ongoing research. As a result, the potential for adhesive failure limits the widespread adoption of tissue adhesives in certain medical procedures, restraining market growth.
Manufacturers are addressing this issue through continuous innovation, improving the strength and longevity of adhesives, but until these concerns are fully resolved, the risk of adhesive failure will remain a challenge to broader market acceptance and expansion. Regulatory hurdles pose a significant challenge to the growth of the global tissue adhesives market, as strict regulations and lengthy approval processes can delay the introduction of innovative products, restrict market entry, and increase overall costs for manufacturers. Tissue adhesives, particularly advanced formulations incorporating nanotechnology, biocompatible polymers, and other novel materials, are subject to stringent regulatory requirements imposed by health authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other global regulatory bodies. These agencies require extensive clinical trials, safety evaluations, and biocompatibility testing before approval, often extending the time-to-market for new products. Furthermore, the varying regulatory standards across regions can complicate international market entry, as manufacturers must navigate different guidelines for each market. This fragmented regulatory landscape increases costs and complexity for companies looking to expand their product offerings globally.
While regulatory approval is essential for ensuring the safety and efficacy of tissue adhesives, these hurdles can limit the pace of technological advancements and inhibit the broader adoption of tissue adhesives, ultimately restraining market growth. As the market becomes more competitive, addressing these regulatory challenges through streamlined approval pathways and harmonized standards could help accelerate the growth of the tissue adhesives market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Tissue Adhesives Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Melsungen, Germany Founded: 1839 Workforce: ~ 66,234 Company Working: B. Braun SE (B. Braun) is a manufacturer and supplier of healthcare products for hospitals, surgical units, private practices (medical care and doctors’ offices), and extracorporeal blood treatments. Its key business areas include clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopedics, spine, and wound care, among others. The company operates through four major business segments, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum. With these four divisions, the company offers over 5,000 products, out of which it manufactures 95% of the products. Geographically it operates in 64 countries across Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It operates through various subsidiaries such as B. Braun Medical Inc., Aesculap AG, and B. Braun Avitum France SAS, among others.
24 interactive charts drawn from the Tissue Adhesives Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Tissue Adhesives Market By Region
Global Tissue Adhesives Market By Research Laboratories & Institutes
Global Tissue Adhesives Market By Ambulatory Surgical Centers (Ascs)
Global Tissue Adhesives Market By Hospitals And Specialty Clinics
Global Tissue Adhesives Market By Thoracic Surgery
Global Tissue Adhesives Market By Urological Surgery
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
